Patents by Inventor Elihu Young

Elihu Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180237487
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: April 19, 2018
    Publication date: August 23, 2018
    Inventors: Andrew SEGAL, Elihu Young
  • Patent number: 9951113
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: April 24, 2018
    Assignee: OpSaniTx LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20170088595
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: November 8, 2016
    Publication date: March 30, 2017
    Inventors: Andrew H. SEGAL, Elihu YOUNG
  • Patent number: 9597394
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: March 21, 2017
    Assignee: OpSaniTx LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20150297715
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: January 26, 2015
    Publication date: October 22, 2015
    Inventors: Andrew H. Segal, Elihu Young
  • Patent number: 8940307
    Abstract: The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: January 27, 2015
    Assignee: Opsanitx LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20100292453
    Abstract: The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
    Type: Application
    Filed: December 21, 2009
    Publication date: November 18, 2010
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20050064391
    Abstract: The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
    Type: Application
    Filed: September 19, 2003
    Publication date: March 24, 2005
    Inventors: Andrew Segal, Elihu Young
  • Publication number: 20040241137
    Abstract: The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
    Type: Application
    Filed: September 19, 2003
    Publication date: December 2, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040180389
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: September 16, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040170960
    Abstract: The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
    Type: Application
    Filed: September 19, 2003
    Publication date: September 2, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040151728
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: August 5, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040142889
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: July 22, 2004
    Applicant: Genitrix,LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040126357
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: July 1, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040126793
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: July 1, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040122217
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: September 19, 2003
    Publication date: June 24, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Publication number: 20040091503
    Abstract: The present invention provides a fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide, as well as a vector comprising a nucleic acid encoding for such a fusion polypeptide, and a host cell comprising such nucleic acid. The present invention also provides a composition comprising an antigen bearing target and such a fusion polypeptide, as well as a composition comprising a virus or a cell and such a fusion polypeptide. The present invention further relates to a method of modulating an immune response in an animal using such compositions.
    Type: Application
    Filed: August 20, 2003
    Publication date: May 13, 2004
    Applicant: Genitrix, LLC
    Inventors: Andrew H. Segal, Elihu Young
  • Patent number: 5516657
    Abstract: The invention provides Baculovirus vectors comprised of a promoter upstream from a signal peptide. The Baculovirus vectors allow for the expression of a glycosylated protein in the late term of Baculovirus infection. Methods for the construction of such a Baculovirus vector are also provided. In addition, methods for producing large amounts of a desired glycosylated protein in the late term infection of Baculovirus infection are also provided.
    Type: Grant
    Filed: March 5, 1993
    Date of Patent: May 14, 1996
    Assignee: Cambridge Biotech Corporation
    Inventors: Cheryl I. Murphy, Elihu Young